Transforming the Diagnosis and Management of Preeclampsia 

Click here to watch the video

Learn more about Carmenta.

Watch the Video.

Current News 

Carmenta CEO, Matthew Cooper, heralds recent developments in Alnylam's new drug for preeclampsia in the latest issue of SciBx.

Life Science Angels Ranked the Top Angel Investment Group in the U.S.

Executives At Disrupt Say The Future Of Healthcare Depends On Testing, Sensing And Communication

Read more News